伊贝沙坦联用比索洛尔对慢性心衰患者细胞因子和心功能的影响(3)
 |
| 第1页 |
参见附件(2969KB，3页)。
[5] Coats AJ. Angiotension type-1 receptor blockers in heart failure[J]. Prog Cardiovasc Dis，2002，44(4)：231-242.
[6] Shaw SM，Coppinger T，Waywell C，et al. The effect of beta-blockers on the adaptive immune system in chronic heart failure[J]. Cardiovasc Ther，2009，27(3)：181-186.
[7] Prabhu SD. Cytokine-induced modulation of cardiac function[J]. Circ Res，2004，95(3)：1140–1153.
[8] Kiczak L，Paslawska U，Bania J，et al. Increased expression of interleukin-1beta and its novel splice variant in canine hearts with volume overload[J]. Cytokine，2008，44(3)：352-360.
[9] Von Haehling S，Schefold JC，Jankowska E，et al. Leukocyte redistribution：effects of beta blockers in patients with chronic heart failure[J]. PLo S One，2009，4(7)：e6411.
[10] Huittinen T，Leinonen M，Tenkanen L，et al. Synergistic effect of persistent Chlamydia pneumonia infection， autoimmunity，and inflammation on coronary risk[J]. Circulation，2003，107(20)：2566-2570.
[11] Kalinowski L，Matys T，Chabielska E，et al. Angiotension Ⅱ AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release[J]. Hypertension，2002，40(4)：521-527.
[12] Adamopoulos S，Parissis JT，Kremastinos DT. A glossary of circulating cytokines in chronic heart failure[J]. Eur J Heart Fail，2001，3：517-526.
(收稿日期：2011-07-28)
您现在查看是摘要介绍页，详见PDF附件(2969KB，3页)。